The observed toxicity and carcinogenicity
of 1,3-dichloro-2-propanol
(DCP) in rodents is thought to be due to the formation of reactive
metabolites, epichlorohydrin (ECH) and dichloroacetone (DCA). However,
there is no direct evidence for the formation of these metabolites
from exposure to DCP in rodents due to the challenges of measuring
these reactive intermediates directly in vivo. The
objective of this work was to investigate the metabolism of DCP to
ECH and DCA in vivo by first developing a sensitive
analytical method in a suitable biological matrix and analyzing samples
from rats administered DCP. DCA reacted rapidly in vitro in rat blood, plasma, and liver homogenate, precluding its detection.
Because ECH rapidly disappeared in liver homogenate, but was relatively
long-lived in plasma and blood in vitro, blood was
selected for analysis of this metabolite. Following a single oral
dose of 50 mg/kg DCP in male or female Harlan Sprague–Dawley
rats, ECH was detected in blood with a maximum concentration reached
at ≤13.7 min. ECH was cleared rapidly with a half-life of ca.
33 and 48 min in males and females, respectively. Following a single
oral dose of 25 mg/kg ECH in male and female rats, the elimination
half-life of ECH was ca. 34 and 20 min, respectively; the oral bioavailability
of ECH was low (males, 5.2%; females, 2.1%), suggesting extensive
first pass metabolism of ECH following oral administration. The area
under the concentration vs time curve for ECH following oral administration
of DCP and intravenous administration of ECH was used to estimate
the percent of the DCP dose converted to ECH in rats. On the basis
of this analysis, we concluded that in male and female rats following
oral administration of 50 mg/kg DCP, ≥1.26% or ≥1.78%
of the administered dose was metabolized to ECH, respectively.